NDC 53346-1363

DR. RECKEWEG R63 Endangitin Combination product

Aesculus Hippocastanum 2x, Potentilla Anserina 2x, Cuprum Aceticum 6x, Secale Cornutum 4x, Tabacum 4x, Veratrum Album 6x

DR. RECKEWEG R63 Endangitin Combination product is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Pharmazeutische Fabrik Dr. Reckeweg & Co. The primary component is Horse Chestnut; Potentilla Anserina Flowering Top; Cupric Acetate; Claviceps Purpurea Sclerotium; Tobacco Leaf; Veratrum Album Root.

Product ID53346-1363_d858c247-2068-4e99-be9a-7a2cb1ed9e8f
NDC53346-1363
Product TypeHuman Otc Drug
Proprietary NameDR. RECKEWEG R63 Endangitin Combination product
Generic NameAesculus Hippocastanum 2x, Potentilla Anserina 2x, Cuprum Aceticum 6x, Secale Cornutum 4x, Tabacum 4x, Veratrum Album 6x
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date1986-06-01
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NamePHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO
Substance NameHORSE CHESTNUT; POTENTILLA ANSERINA FLOWERING TOP; CUPRIC ACETATE; CLAVICEPS PURPUREA SCLEROTIUM; TOBACCO LEAF; VERATRUM ALBUM ROOT
Active Ingredient Strength2 [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 53346-1363-5

50 mL in 1 BOTTLE (53346-1363-5)
Marketing Start Date1986-06-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 53346-1363-5 [53346136305]

DR. RECKEWEG R63 Endangitin Combination product LIQUID
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date1986-06-01
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
HORSE CHESTNUT2 [hp_X]/50mL

OpenFDA Data

SPL SET ID:aa7de1fd-3dd7-4d99-8652-5186f0484a58
Manufacturer
UNII
UPC Code
  • 0669330001219

  • © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.